KJ-01 (Kiji Therapeutics)

N/A

Report date: 2025/01/22 12:03:46

Base Information

Drug NameKJ-01 (Kiji Therapeutics)
Drug Alias NameKJ-01KJ01
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacementsInterleukin-10 modulatorsC-X-C motif chemokine receptor 4 modulators
TargetsInterleukin-10C-X-C motif chemokine receptor 4
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKiji Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKiji Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A